[Other] Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial.

akoazan Post time The day before yesterday 13:32 | Show all posts |Read mode
Reward10points

10.1038/s41591-024-03133-0
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    760

Latest Reply

Return to the list